New hope for indian CML patients after other treatments fail
NCT ID NCT06427811
Summary
This study is checking the safety and effectiveness of the drug asciminib for adults in India with a specific type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (CML). It is for patients whose cancer has not responded well to at least two other standard treatments, or who have a specific genetic mutation (T315I) that makes the cancer harder to treat. The goal is to see how well the drug works and what side effects it causes in this group over a six-month period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Ahmedabad, Gujarat, 380009, India
-
Novartis Investigative Site
Ahmedabad, Gujarat, 382428, India
-
Novartis Investigative Site
Bengaluru, Karnataka, 560034, India
-
Novartis Investigative Site
Trivandrum, Kerala, 695 011, India
-
Novartis Investigative Site
Pune, Maharashtra, 422001, India
-
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, 431005, India
-
Novartis Investigative Site
Hyderabad, Telangana, 500082, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700014, India
-
Novartis Investigative Site
Cuttack, 753007, India
-
Novartis Investigative Site
Guwahati, 781003, India
Conditions
Explore the condition pages connected to this study.